Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN- α in Chinese Resected Stage III Malignant Melanoma.

CONCLUSION: Patients who undergo surgical excision of stage III MM appear to enjoy prolonged DFS and OS when treated with TIL + IFN-α compared to IFN-α alone. PMID: 28913367 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28913367?dopt=Abstract

Source: Journal of Immunology Research - September 17, 2017 Category: Allergy & Immunology Tags: J Immunol Res Source Type: research